Invited speakers (confirmed):
• Prof. Justus Adamson, Duke University, NC, USA: "Linac-synchronized 3D dosimetry using kV-CBCT and NIPAM polymer gels."
• Dr. Emily Cloutier, McGill University, Montreal, Quebec, Canada: “”Polarization Imaging: Applications for Conventional and FLASH Cherenkov Measurements”
• Dr. Consuelo Guardiola, Institute of Microelectronics of Barcelona (IMB-CNM, CSIC), Universitat Autònoma de Barcelona, Barcelona, Spain: “First experimental microdosimetry 2D-maps in proton therapy based on new microdetector arrays” (tentative title)
• Dr. Mads Lykke Jensen, Aarhus University, Aarhus, Denmark: “Three-dimensional dose measurements using optically stimulated luminescence” (tentative title)
• Prof. Katia Parodi, Dept. of Medical Physics, Faculty of Physics, Ludwig-Maximilians-Universität München, Munich, Germany: "Commissioning a novel radiation research platform for precision image-guided proton therapy".
• Dr. Patrick Pittet, INL CNRS-Université de Lyon, France: “Use of tomographic approaches and semiconductor QDots for innovation in mini and microbeam radiotherapy dosimetry” (tentative title)
• Prof. Brian Pogue, University of Wisconsin-Madison, WI, USA: “Cherenkov surface guidance and temporal dosimetry in Conventional and FLASH RT”
• Prof. Ryan L Smith, Alfred Hospital, Melbourne, Australia: "Treatment Verification in High Dose Rate Brachytherapy".
• Dr. Eduardo Yukihara, Head of the Radiation Metrology Section, Paul Scherrer Institut, Villigen, Switzerland: “Recent Progress on Optically Stimulated Luminescence Dosimetry Applied to FLASH and Ion Beam Therapy”
• Prof. Marek Kozicki, Lodz University of Technology, Lodz, Poland, “Multiphase 3D dosimeters for radiotherapy”
• Dr. Anne-Marie Frelin, GANIL, Caén, Francé, “Development of a new 3-dimensional scintillating detector for patient treatment quality control in pencil beam scanning proton therapy”
• B.E. Megan Clark, Thayer School of Engineering Dartmouth College, Hanover NH, USA, “3D Scintillation Imaging as Versatile Tool for Validation of UHDR Treatment Plans Across Modalities”
